Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Canberra, Australian Capital Territory-based Nexus Synthetics operates in Biotechnology Research. The record marks it privately held. It holds one address on record, all in Australia. It employs 2 people, on the record. One Australian registration (ABN) is a confirmed match. It is listed alongside three similar brands, mostly in Internet & Technology.
ABN88682394467
| NEXUS SYNTHETICS PTY. LTD | ABN 88682394467 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Nexus Synthetics' mission is to enable a data brokerage between hospitals, clinics and healthcare data users via synthetic data generation.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Australian Capital Territory entity on the ABR: NEXUS SYNTHETICS PTY. LTD (ABN 88 682 394 467), high confidence.
2 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Canberra, Australian Capital Territory 2914.
None linked to this brand.
2 profiles list Nexus Synthetics as a peer — 42nd percentile in Biotechnology Research. It lists eight peers of its own. Agir Labs and Universe Group list it back.